168 related articles for article (PubMed ID: 37795393)
21. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis.
Haley ML; Gerszten PC; Heron DE; Chang YF; Atteberry DS; Burton SA
J Neurosurg Spine; 2011 Apr; 14(4):537-42. PubMed ID: 21314284
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord Compression.
Ito K; Sugita S; Nakajima Y; Furuya T; Hiroaki O; Hayakawa S; Hozumi T; Saito M; Karasawa K
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):106-113. PubMed ID: 34715257
[TBL] [Abstract][Full Text] [Related]
24. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic body radiation therapy (SBRT) for spinal metastases: 12 years of a single center experience.
Ciérvide R; Hernando O; López M; Montero Á; Zucca D; Sánchez E; Álvarez B; García-Aranda M; Chen Zhao X; Valero J; Alonso R; Martí J; de la Casa MÁ; Alonso L; García J; Garcia de Acilu P; Prado A; Fernandez Leton P; Rubio C
Clin Transl Oncol; 2023 Dec; 25(12):3395-3404. PubMed ID: 37058207
[TBL] [Abstract][Full Text] [Related]
26. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
27. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959
[TBL] [Abstract][Full Text] [Related]
28. Myositis following spine radiosurgery for metastatic disease: a case series.
Lockney DT; Jia AY; Lis E; Lockney NA; Liu C; Hopkins B; Higginson DS; Yamada Y; Laufer I; Bilsky M; Schmitt AM
J Neurosurg Spine; 2018 Apr; 28(4):416-421. PubMed ID: 29372858
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
30. Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.
Jiang P; Krockenberger K; Vonthein R; Tereszczuk J; Schreiber A; Liebau S; Huttenlocher S; Imhoff D; Balermpas P; Keller C; Dellas K; Baumann R; Rödel C; Hildebrandt G; Jünemann KP; Merseburger AS; Katz A; Ziegler A; Blanck O; Dunst J
Radiat Oncol; 2017 Aug; 12(1):138. PubMed ID: 28821268
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
[TBL] [Abstract][Full Text] [Related]
33. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
Zeng KL; Myrehaug S; Soliman H; Husain ZA; Tseng CL; Detsky J; Ruschin M; Atenafu EG; Witiw CD; Larouche J; da Costa L; Maralani PJ; Parulekar WR; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):293-300. PubMed ID: 35675854
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262
[TBL] [Abstract][Full Text] [Related]
35. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis.
Tchelebi LT; Lehrer EJ; Trifiletti DM; Sharma NK; Gusani NJ; Crane CH; Zaorsky NG
Cancer; 2020 May; 126(10):2120-2131. PubMed ID: 32125712
[TBL] [Abstract][Full Text] [Related]
36. Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases - a randomized phase III study.
Bludau F; Welzel G; Reis T; Abo-Madyan Y; Sperk E; Schneider F; Clausen S; Ruder AM; Obertacke U; Ghaly MM; Wenz F; Giordano FA
BMC Cancer; 2019 May; 19(1):430. PubMed ID: 31072314
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
[TBL] [Abstract][Full Text] [Related]
38. Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer.
Zelefsky MJ; Yamada Y; Greco C; Lis E; Schöder H; Lobaugh S; Zhang Z; Braunstein S; Bilsky MH; Powell SN; Kolesnick R; Fuks Z
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):672-679. PubMed ID: 33422612
[TBL] [Abstract][Full Text] [Related]
39. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
[TBL] [Abstract][Full Text] [Related]
40. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
